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In a recent issue of Respiratory Medicine (l), Patkas et al. 
have reported that salmeterol or ipratropium bromide 
produces significant improvement in airway obstruction in 
the recovery of post-exercise HbO, desaturation and in 
dyspnoeic sensation in patients with chronic obstructive 
pulmonary disease (COPD). We basically agree with the 
authors that both inhaled agents, i.e. salmeterol (a 
/I-adrenergic agent) and ipratropium bromide (an anti- 
cholinergic agent), are very beneficial in terms of reducing 
breathlessness and improving the exercise performance in 
patients with COPD. The current observations were in 
agreement with the data from our and previous other 
studies (2-7). However, gas exchange before and after 
administration of the bronchodilatory agents in patients 
with asthma and COPD is still a matter of debate. Gross 
and Bankwala demonstrated that nebulised atropine 
methonitrate (an anticholinergic agent) had no significant 
effect on gas exchange in hypoxaemic patients with COPD; 
however, metaproterenol hydrochloride elicited a signifi- 
cant decrease in PaO, (8). Igarashi et al. have reported that 
fenoterol (a /3-adrenergic agent) and oxitropium bromide 
(an anticholinergic agent) improved FEV, by 21 and 16% in 
COPD patients without hypoxaemia, respectively, and that 
the mean value of PaO, decreased from 74.5 to 69.3 torr 
with fenoterol, but not with oxitropium and placebo (9). 
The current study further indicates that nadir SaO, and the 
recovery of post-exercise hypoxaemia are better after inha- 
lation of an anticholinergic agent than those after inhala- 
tion of a /I-adrenergic agent in patients with stable COPD. 
These observations suggest that an inhaled anticholinergic 
agent is more favourable for patients with COPD than a 
Badrenergic agent from the viewpoints of gas exchange at 
rest and during exercise. 
Finally, analytical indices such as BS,,,, TLD, BLD, 
and the recovery time for SaO, in the current study were 
fairly similar to those determined in our studies (24,lO). 
Although the methodology was different (the current study 
used a walking test and our study used a cycle ergometer), 
the concepts should be more appropriately quoted. As one 
of the major goals of bronchodilator therapy in patients 
with COPD may be to relieve dyspnoea on exertion, we 
believe that the quantitative parameters for assessment of 
dyspnoea should be carefully and widely used in the clinical 
setting. 
S. TERAMOTO AND Y. OUCHI 
Department of Geriatric Medicine, 
Tokyo University Hospital, Japan 
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